• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

INCY:US

75.0100 USD 1.8700 2.56%

As of 15:59:58 ET on 11/26/2014.

Snapshot for Incyte Corp (INCY)

Open: 73.1000 Day's Range: 72.8200 - 75.0100 Volume: 728,100
Previous Close: 73.1400 52wk Range: 40.3000 - 75.8800 1-Yr Rtn: +57.85%

Stock Chart for INCY

No chart data available.
  • INCY:US 74.9300
  • 1D
  • 1M
  • 1Y
73.1400
Interactive INCY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for INCY

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.2908
Est. EPS (USD) (12/2014) -0.0380
Est. PEG Ratio -
Market Cap (M USD) 12,543.93
Shares Outstanding (M) 168.94
30 Day Average Volume 1,579,960
Price/Book (mrq) -
Price/Sale (ttm) 25.6724
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for INCY

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for INCY

Incyte Corp is a biopharmaceutical company. The Company discovers, develops and commercializes proprietary small molecule drugs, primarily used in oncology.

Herve HoppenotPresident/CEODavid W Gryska "Dave"Exec VP/CFO
James M Daly "Jim"Exec VP/Chief Commercial OfcrRichard S LevyExec VP/Chief Drug Dev & Medical Ofcr
More Company Profile & Key Executives for INCY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil